News GSK COPD combination better than AZ rival - trial GSK plans to file triple combination therapy by end of the year.
News AZ sells US, EU and Latin America rights to gout drug AZ focused on sales target set by CEO Pascal Soriot.
News AstraZeneca unveils genomics collaboration to aid drug disco... AstraZeneca has launched a new 'integrated genomics approach' to expand the genetic basis of its research, and aid drug discovery and development.
Articles AstraZeneca, Genentech fund PatientsLikeMe research into can... PatientsLikeMe is working with AstraZeneca and Roche to find about more about the experiences of people being treated for lung cancer
News Lilly pays AstraZeneca $100m as Alzheimer's drug enters phas... AstraZeneca and Eli Lilly are to continue with a pivotal phase 2/3 study of a key pipeline drug, AZD3293 for early Alzheimer's disease, after interim safety data boosted confidence in the d
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
